Interview with Gordon Bates, Head of Operations and Site Manager, Lonza UK
Can you provide us with an overview of what the UK market represents for the greater Lonza group? Lonza Biologics…
Lonza UK
Last updated: 13.02.2014
Address: 228 Bath Road, Slough, Berkshire, SL1 4DX, Great Britain,United Kingdom
Tel: +44 1753 777000
Company description
Lonza is one of the world’s leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Products and services
To provide optimal support to our customers, we are organized in businesses that focus on specific sets of customers and their exact needs. We operate as three divisions: Life Science ingredients, Custom Manufacturing and Bioscience.
Interviews
Related
HIV ‘Cure’ on the Horizon? London Patient Cleared of AIDS Virus
Hopes have been raised of a cure for AIDS after a patient in London became free of the HIV virus following a bone…
Company Profile: GW Pharmaceuticals
Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company…
The European Medicines Verification System Launches to Tackle Fake Drugs
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…
The UK to Incentivise Big Pharma Firms to Develop New Antibiotics
In recent years, apocalyptic conversations around superbugs caused by antimicrobial resistance (AMR) have been on…
The 5 Most Influential Medical Research Charities in the UK
An unusual characteristic of the UK’s healthcare landscape is that charities fund the vast majority of…
GSK and Pfizer Consumer Health Divisions to Merge
The two Big Pharma giants today announced the merger between their consumer healthcare businesses, with the joint…
The Line Manager of Tomorrow
Ian Chamberlain looks at the changing role of the pharma sales manager and the skills needed to keep up with new…
Nationalism & Populism: A Roadblock for Global Pharma
Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In his second piece for PharmaBoardroom,…
The Changing Role of the Medical Rep
With more than 25 years pharmaceutical industry experience, Ian Chamberlain provides training to help pharma…
Brexit uncertainty forces AstraZeneca to freeze investment in the UK
Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…
The UK will add folic acid to flour to reduce defects in newborns
The UK Prime Minister has been convinced by medical professionals to fortify all flour with folic acid to reduce…
NHS launches a new era of genomic medicine
This week the NHS becomes the first in the world to routinely offer access to breakthrough genomic medicine. Today…
